Replies to post #493139 on Anavex Life Sciences Corp (AVXL)

[Lacey1]

Any buyout should be north of 70 billion. Eli Lilly could do it easily. We are not in a hurry. The EMA is working. With approval we start trials in Rhett, Parkinsons, dementia, fragil x, and more. Revenue stream in five years with prophylactic use?